Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina

Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a l... Devices, Interventional, Cardiology, Reimbursement Neovasc , Reducer, angina pectoris, refractory angina
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news